Why the study?
The Asia-Pacific region previously lacked comprehensive APHRS guidelines integrating contemporary global evidence with region-specific data and clinical considerations for stroke prevention in atrial fibrillation.
Provides the first comprehensive Asia Pacific Heart Rhythm Society (APHRS) evidence-based guidelines tailored to the Asia-Pacific region for stroke prevention, oral anticoagulation dosing, and left atrial appendage occlusion in patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May inform Asia-Pacific AF anticoagulation decisions; leaves open prospective validation of recommendations.
The 2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines represent the first comprehensive APHRS guidelines dedicated to the management of atrial fibrillation (AF) and comprise four parts covering epidemiology, detection/screening and integrated care; stroke prevention; rate and rhythm control; and lifestyle risk factor and comorbidity management. Part II focuses on stroke prevention in AF, integrating contemporary global evidence with data and clinical considerations specific to the Asia‐Pacific region. It provides evidence‐based and practical recommendations for stroke and bleeding risk assessment, oral anticoagulation, selection and appropriate dosing of direct oral anticoagulants, management of patients with special or complex clinical characteristics, and left atrial appendage occlusion. Particular attention is given to issues (and evidence) highly relevant to Asia‐Pacific populations, including the evolving risk of ischemic stroke, appropriate anticoagulant dosing, renal function assessment, and balancing thromboembolic and bleeding risks. These recommendations aim to support individualized clinical decision‐making, promote appropriate use of stroke‐prevention strategies, and improve outcomes for patients with AF across the Asia‐Pacific region.
No takes yet. Share an insight, caveat, or question.
Chao et al. (2026) studied Atrial fibrillation. Oral anticoagulation, direct oral anticoagulants, and left atrial appendage occlusion was evaluated on Stroke prevention in atrial fibrillation. The 2026 APHRS Guidelines Part II provide evidence-based recommendations on oral anticoagulation, DOAC dosing, and left atrial appendage occlusion for stroke prevention in atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: